Close



Apr 2, 2024 06:52AM
Mar 27, 2024 07:07AM
Mar 27, 2024 07:00AM
Nov 7, 2023 07:00AM
Oct 26, 2023 07:31AM
Oct 26, 2023 07:30AM
Mar 15, 2022 07:01AM Altimmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update
Jan 31, 2022 07:02AM
Jan 31, 2022 07:00AM
Dec 13, 2021 04:52AM
Dec 13, 2021 01:00AM
Nov 9, 2021 04:01PM
Oct 4, 2021 07:00AM
Sep 28, 2021 07:04AM Altimmune (ALT) Announces Positive Results From 12-week Phase 1 Clinical Trial of ALT-801 (Pemvidutide) in Overweight and Obese Volunteers
Sep 28, 2021 07:01AM
Apr 16, 2021 07:30AM
Feb 17, 2021 07:06AM
Feb 17, 2021 07:02AM
Dec 30, 2020 08:02AM
Dec 30, 2020 08:00AM
Dec 24, 2020 09:09AM Pre-Open Stock Movers 12/24: (BABA) (SENS) (TNXP) (GEVO) (ALT) (more...)
Dec 23, 2020 05:23PM
Dec 23, 2020 04:03PM
Dec 23, 2020 04:01PM
Dec 8, 2020 08:06AM
Dec 8, 2020 08:00AM
Nov 25, 2020 07:02AM
Nov 25, 2020 07:00AM Altimmune Announces Submission of Investigational New Drug Application for AdCOVID™ a Single-dose Intranasal COVID-19 Vaccine; On Track to Commence Phase 1 Clinical Study in December
Nov 23, 2020 05:23PM
Nov 10, 2020 01:00AM
Oct 12, 2020 07:01AM
Oct 12, 2020 07:01AM
Sep 28, 2020 04:01PM
Sep 1, 2020 07:07AM
Sep 1, 2020 07:00AM Altimmune Announces Successful Completion of Multiple Dose Toxicity and Toxicokinetic Studies of ALT-801, a GLP-1/Glucagon Dual Receptor Agonist for the Treatment of NASH
Aug 26, 2020 07:00AM
Aug 25, 2020 07:08AM
Aug 25, 2020 07:00AM
Aug 11, 2020 04:05PM
Jul 22, 2020 07:31AM
Jul 22, 2020 07:30AM
Jul 15, 2020 09:30AM Pre-Open Stock Movers 07/15: (FVAC) (MRNA) (CCL) Higher; (VXRT) (ZYXI) (BK) Lower (more...)
Jul 14, 2020 09:24AM
Jul 13, 2020 05:35PM
Jul 13, 2020 07:08AM
Jul 13, 2020 07:00AM
Jul 9, 2020 07:06AM
Jul 9, 2020 07:00AM
Jun 29, 2020 09:31AM Pre-Open Stock Movers 06/29: (KNSA) (WKHS) (COTY) Higher; (ICPT) (HRTX) (BYND) Lower (more...)
Jun 29, 2020 07:10AM

251,872 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All